{
    "symbol": "TKNO",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-15 07:37:23",
    "content": " We remain focused on the following priorities: First, to deliver revenue between $45 million and $48 million, a growth rate of greater than 30% at the midpoint, excluding Sample Transport; second, to increase our current production capacity and bring our new manufacturing facility online by year-end; third, to build out our commercial and marketing teams and associated capabilities to drive demand before our new facility opens; and lastly, to develop new products to improve efficiency and cell and gene therapy bioproduction."
}